Private Wealth Management Group’s Fennec Pharmaceuticals FENC Stock Holding History

Private Wealth Management Group’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.59K	Sell	243 -4	-2%	-$44	﹤0.01%	1098
2026 Q2	$2.66K	Sell	247 -150	-38%	-$1.22K	﹤0.01%	1065
2026 Q1	$2.44K	Buy	397 +150	+61%	+$1.16K	﹤0.01%	1022
2025 Q4	$1.9K	Hold	247	–	–	﹤0.01%	1101
2025 Q3	$2.31K	Hold	247	–	–	﹤0.01%	1069
2025 Q2	$2.05K	Sell	247 -182	-42%	-$1.24K	﹤0.01%	1077
2025 Q1	$2.61K	Buy	429 +182	+74%	+$1.17K	﹤0.01%	967
2024 Q4	$1.56K	Buy	+247	New	+$1.26K	﹤0.01%	1181

Other funds holding FENC

Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Private Wealth Management Group's FENC Position: Q3 2026 in Review

Private Wealth Management Group reduced its Fennec Pharmaceuticals (FENC) stake by 1.6% in Q3 2026, selling an estimated $44 and leaving 243 shares worth $2.59K. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

Private Wealth Management Group first reported a position in FENC in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.66K in Q2 2026. 12 funds tracked by Wall St. Rank hold FENC as of Q3 2026.

Private Wealth Management Group held 243 shares of Fennec Pharmaceuticals worth $2.59K as of Q3 2026.
Private Wealth Management Group sold 4 Fennec Pharmaceuticals shares in Q3 2026, an estimated $44.
Fennec Pharmaceuticals made up ﹤0.01% of Private Wealth Management Group's portfolio in Q3 2026, its #1098 holding.
Private Wealth Management Group first reported a position in Fennec Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
Private Wealth Management Group's Fennec Pharmaceuticals position peaked at $2.66K in Q2 2026.
12 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.

Based on Private Wealth Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.